Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis
Authors
Keywords
-
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 128, Issue 1, Pages 49-60
Publisher
Springer Science and Business Media LLC
Online
2020-12-02
DOI
10.1007/s00702-020-02276-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factors associated with hospitalisation among people with Parkinson's disease – A systematic review and meta-analysis
- (2020) Olaitan Okunoye et al. PARKINSONISM & RELATED DISORDERS
- Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson’s Disease Patients
- (2020) M. Klietz et al. Parkinsons Disease
- Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson’s Disease
- (2020) Francis Feldmann et al. Parkinsons Disease
- Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- (2019) Klaus Seppi et al. MOVEMENT DISORDERS
- Systematic Literature Review of Quetiapine for the Treatment of Psychosis in Patients With Parkinsonism
- (2019) Jack J. Chen et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Potentially Inappropriate Prescribing and Related Hospital Admissions in Geriatric Patients: A Comparative Analysis between the STOPP and START Criteria Versions 1 and 2
- (2019) Stefanie Thevelin et al. DRUGS & AGING
- Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients
- (2019) Martin Klietz et al. DRUGS & AGING
- The FORTA (Fit fOR The Aged) List 2018: Third Version of a Validated Clinical Tool for Improved Drug Treatment in Older People
- (2019) Farhad Pazan et al. DRUGS & AGING
- Polypharmacy in Parkinson’s disease: risks and benefits with little evidence
- (2019) I. Csoti et al. JOURNAL OF NEURAL TRANSMISSION
- The U.S.-FORTA (Fit fOR The Aged) List: Consensus Validation of a Clinical Tool to Improve Drug Therapy in Older Adults
- (2019) Farhad Pazan et al. Journal of the American Medical Directors Association
- The Use of Benzodiazepine Receptor Agonists and the Risk of Hospitalization for Pneumonia
- (2018) Tien-Yu Chen et al. CHEST
- The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People
- (2018) Farhad Pazan et al. DRUGS & AGING
- Prevalence and Preventability of Drug-Related Hospital Readmissions: A Systematic Review
- (2018) Najla El Morabet et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- Advances in Pharmacotherapy of Late-Life Depression
- (2018) John L. Beyer et al. Current Psychiatry Reports
- Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis
- (2018) Marina Guisado-Clavero et al. BMC Geriatrics
- Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson’s Disease Patients
- (2018) Martin Klietz et al. Frontiers in Neurology
- Potentially Inappropriate Medications in the Elderly
- (2018) Stefanie Holt et al. Deutsches Arzteblatt International
- Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson’s Disease: A Cross-Sectional Study
- (2018) Marina Peball et al. GERONTOLOGY
- Charakteristika und Dynamik der stationären Behandlung von Parkinson-Patienten in Deutschland
- (2018) L. Tönges et al. NERVENARZT
- Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis
- (2017) T. J. Oscanoa et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
- (2017) Wolfgang Oertel et al. MOVEMENT DISORDERS
- Morbus Parkinson im Alter
- (2017) Rüdiger Lange et al. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
- VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification
- (2016) Martin Wehling et al. AGE AND AGEING
- Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its Operationalization
- (2016) Amaia Calderón-Larrañaga et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
- (2016) Joaquim J Ferreira et al. LANCET NEUROLOGY
- Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies
- (2016) Matej Markota et al. MAYO CLINIC PROCEEDINGS
- Benzodiazepines and risk of death: Results from two large cohort studies in France and UK
- (2015) Aurore Palmaro et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Health-related quality of life in Parkinson’s disease: a cross-sectional study focusing on non-motor symptoms
- (2015) Liis Kadastik-Eerme et al. Health and Quality of Life Outcomes
- Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta-Analysis
- (2015) Kristian Thorlund et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Relationship between the non-motor items of the MDS–UPDRS and Quality of Life in patients with Parkinson's disease
- (2015) Matej Skorvanek et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review
- (2015) Alexandra Martini de Oliveira et al. Biomed Research International
- Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study
- (2015) Kara M. Smith et al. JAMA Neurology
- Association between Benzodiazepine Use and Dementia: A Meta-Analysis
- (2015) GuoChao Zhong et al. PLoS One
- Drug-drug interaction software in clinical practice: a systematic review
- (2014) Tina Roblek et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
- (2014) R. A. Hauser et al. EUROPEAN JOURNAL OF NEUROLOGY
- A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia
- (2014) Gill Livingston et al. HEALTH TECHNOLOGY ASSESSMENT
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease
- (2014) Robert A. Hauser et al. MOVEMENT DISORDERS
- Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis
- (2014) Supinya Dechanont et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)
- (2014) Michel Panisset et al. PHARMACOTHERAPY
- Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the Elderly
- (2013) Alexandra M. Kuhn-Thiel et al. DRUGS & AGING
- Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial
- (2013) Eduardo Tolosa et al. JOURNAL OF NEURAL TRANSMISSION
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- (2013) Jeffrey Cummings et al. LANCET
- Transdermal rotigotine in early stage Parkinson's disease: A randomized, double-blind, placebo-controlled trial
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Association between use of benzodiazepines and risk of fractures: a meta-analysis
- (2013) D. Xing et al. OSTEOPOROSIS INTERNATIONAL
- Drug-drug interactions in a cohort of hospitalized elderly patients
- (2013) Luca Pasina et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Melatonin Prolonged Release
- (2012) Katherine A. Lyseng-Williamson DRUGS & AGING
- Drug-drug interactions at hopital admission in geriatric patients in a single facility: a retrospective study
- (2012) Rosalinda Sánchez-Arenas et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Assessment of appropriate medication administration for hospitalized patients with Parkinson’s disease
- (2012) Jyhgong Gabriel Hou et al. PARKINSONISM & RELATED DISORDERS
- Evaluation of drug–drug interaction screening software combined with pharmacist intervention
- (2012) Cristiano S. Moura et al. International Journal of Clinical Pharmacy
- Potentially Harmful Drug–Drug Interactions in the Elderly: A Review
- (2011) Lisa E. Hines et al. American Journal Geriatric Pharmacotherapy
- Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function
- (2011) Willi Cawello et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Psychotropic Drug-Induced Falls in Older People
- (2011) Keith D. Hill et al. DRUGS & AGING
- STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation
- (2011) P. Gallagher et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Emergency Hospitalizations for Adverse Drug Events in Older Americans
- (2011) Daniel S. Budnitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
- (2011) Hideyuki Sawada et al. PLoS One
- Preventable hospital admissions related to medication (HARM): Cost analysis of the HARM study
- (2011) Anne J. Leendertse et al. VALUE IN HEALTH
- Citalopram versus other antidepressants for late-life depression: a systematic review and meta-analysis
- (2010) Dallas P. Seitz et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson’s disease
- (2010) Hiroshi Nagayama et al. PARKINSONISM & RELATED DISORDERS
- Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease
- (2010) Daniel Truong Clinical Interventions in Aging
- The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia
- (2009) Remy Luthringer et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Prevalence of Frailty in Middle-Aged and Older Community-Dwelling Europeans Living in 10 Countries
- (2009) B. Santos-Eggimann et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
- (2009) Herbert Y Meltzer et al. NEUROPSYCHOPHARMACOLOGY
- Escitalopram in the Acute Treatment of Depressed Patients Aged 60 Years or Older
- (2007) Anjana Bose et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Apomorphine for the acute treatment of “off” episodes in Parkinson's disease
- (2007) Mark Stacy et al. PARKINSONISM & RELATED DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now